Related Experiment Videos
The inhibition of plasmin by antithrombin-heparin complex. I. In human plasma in vitro
British Journal of Haematology
|May 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Correlation between oxidized low density lipoproteins and von Willebrand factor in chronic renal failure.
Thrombosis and haemostasis·1996
Characterization of the murine plasminogen/urokinase-type plasminogen-activator system.
European journal of biochemistry·1996
A pilot study on bolus administration of recombinant staphylokinase for coronary artery thrombolysis.
Thrombosis and haemostasis·1996
Effects of deletion of the carboxyl-terminal domain of ApoA-I or of its substitution with helices of ApoA-II on in vitro and in vivo lipoprotein association.
The Journal of biological chemistry·1996
SENIOR-IPI: An easily applicable prognostic index for first-line large B-cell lymphomas patients >80 years treated with curative intent.
British journal of haematology·2026
CALR-mutated myeloproliferative neoplasms: Refining molecular risk beyond the driver.
British journal of haematology·2026
RESOLVE to do better.
British journal of haematology·2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.
British journal of haematology·2026
Development and validation of a model for stratifying haematological malignancy risk in primary care using basic blood tests.
British journal of haematology·2026
Prolonged low-dose intravenous thrombolysis in early recurrent stroke.
Neurologia i neurochirurgia polska·2026
HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study.
The Lancet regional health. Western Pacific·2026
Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data.
Journal of pharmaceutical policy and practice·2026